Technical Analysis for VIVO - Meridian Bioscience Inc.

Grade Last Price % Change Price Change
grade F 10.88 -1.89% -0.21
VIVO closed down 1.89 percent on Friday, May 17, 2019, on approximately normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical VIVO trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -1.89%
Down 3 Days in a Row Weakness -1.89%
Down 4 Days in a Row Weakness -1.89%
Down 5 Days in a Row Weakness -1.89%

Older signals for VIVO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Meridian Bioscience, Inc., a life science company, develops, manufactures, sells, and distributes clinical diagnostic test kits primarily for gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company's diagnostic products principally include C. difficile for the detection of gastrointestinal diseases, such as antibiotic-associated diarrhea; Rotavirus and Adenovirus products for pediatric diarrhea detection; H. pylori for the detection of stomach ulcers; EHEC test for the detection of Enterohemorrhagic E. coli infection and Campy for the detection of Campylobacter jejuni; and Group A Strep and Group B Strep tests for the detection of streptococcus bacterial infections. Its diagnostic products are also used in the detection of viral diseases, such as mononucleosis, herpes simplex, chicken pox, and shingles; organ transplant infections; parasitic diseases, including giardiasis, cryptosporidiosis, and lyme; and respiratory diseases, such as pneumonia, valley fever, influenza, and respiratory syncytial virus. The company also offers transport media that store and preserve specimen samples from patient collection to laboratory testing; and bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic companies. In addition, it engages in the contract development and manufacture of proteins and other biologicals under cGMP conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines; and sale and distribution of diagnostic test kits manufactured by third-party vendors. The company markets its products through direct sales force and independent distributors primarily to hospitals, reference laboratories, and research customers in the United States, Asia, Canada, South America, Australia, Europe, Africa, and the Middle East. Meridian Bioscience, Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio.
Medicine Biotechnology Antibodies Influenza Diagnostic Products Diarrhea Gastrointestinal Diseases Respiratory Diseases Viral Diseases Herpes Simplex Pneumonia Shingles Zoonoses Human Orthopneumovirus Organ Transplant Waterborne Diseases
Is VIVO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 19.84
52 Week Low 10.81
Average Volume 417,692
200-Day Moving Average 15.8005
50-Day Moving Average 13.9298
20-Day Moving Average 11.937
10-Day Moving Average 11.391
Average True Range 0.4896
ADX 46.29
+DI 11.372
-DI 35.3491
Chandelier Exit (Long, 3 ATRs ) 12.2112
Chandelier Exit (Short, 3 ATRs ) 12.2788
Upper Bollinger Band 13.4711
Lower Bollinger Band 10.4029
Percent B (%b) 0.16
BandWidth 25.703276
MACD Line -0.7664
MACD Signal Line -0.799
MACD Histogram 0.0326
Fundamentals Value
Market Cap 459.17 Million
Num Shares 42.2 Million
EPS 0.50
Price-to-Earnings (P/E) Ratio 21.76
Price-to-Sales 3.13
Price-to-Book 3.70
PEG Ratio 1.29
Dividend 0.50
Dividend Yield 4.60%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.39
Resistance 3 (R3) 11.42 11.29 11.31
Resistance 2 (R2) 11.29 11.16 11.27 11.28
Resistance 1 (R1) 11.08 11.08 11.02 11.05 11.25
Pivot Point 10.95 10.95 10.91 10.93 10.95
Support 1 (S1) 10.74 10.82 10.68 10.71 10.51
Support 2 (S2) 10.61 10.74 10.59 10.48
Support 3 (S3) 10.40 10.61 10.46
Support 4 (S4) 10.37